Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL684P is a pseudogene derived from the 7SL RNA gene, which is a non-coding RNA component of the signal recognition particle (SRP) complex involved in co-translational protein targeting to the endoplasmic reticulum. Most 7SL-related sequences in the human genome are processed pseudogenes resulting from retrotransposition of 7SL RNA transcripts back into DNA, and these sequences are typically truncated and non-functional. While some pseudogenes may play regulatory roles through mechanisms such as microRNA sponging or competition for RNA-binding proteins, there is no published evidence that RN7SL684P is functional or directly involved in disease processes. Substantial literature discusses 7SL RNA (e.g., RN7SL1) as biologically important, but not pseudogenes like RN7SL684P, which are generally considered genomic fossils with no direct mechanistic role in cellular processes or as therapeutic targets[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 684, pseudogene (RN7SL684P).